Understanding the costs and cost-effectiveness of TB treatment in Bangladesh

Location

Bangladesh, Bangladesh

Dates

01/01/2013 - 07/01/2015

PI

David Dowdy, MD, PhD, ScM

We have conducted an empirical costing analysis of facility-based versus community-based treatment for TB in Bangladesh and are using these results to construct models of the cost-effectiveness of novel shorter-course regimens for drug-susceptible TB.

Projects

Modeling the impact of spatially targeted TB...

We have developed transmission models to understand the impact of TB vaccination strategies that target hotspots of...

Read More

MDR TB treatment as prevention: modeling the...

We are using transmission modeling to evaluate the potential impact of expanding DST and access to MDR TB treatment in Vietnam,...

Read More